These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26038582)

  • 1. Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different Locations.
    Stam-Slob MC; van der Graaf Y; de Borst GJ; Cramer MJ; Kappelle LJ; Westerink J; Visseren FL;
    Diabetes Care; 2015 Aug; 38(8):1528-35. PubMed ID: 26038582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: the SMART study.
    Grool AM; van der Graaf Y; Visseren FL; de Borst GJ; Algra A; Geerlings MI;
    J Intern Med; 2012 Sep; 272(3):277-86. PubMed ID: 22257088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender difference in long-term prognosis among patients with cardiovascular disease.
    van der Meer MG; Cramer MJ; van der Graaf Y; Doevendans PA; Nathoe HM;
    Eur J Prev Cardiol; 2014 Jan; 21(1):81-9. PubMed ID: 22952288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk of cardiovascular risk factors and events in offspring of patients at high vascular risk and effect of location of parental vascular disease.
    Weijmans M; van der Graaf Y; de Borst GJ; Asselbergs FW; Cramer MJ; Algra A; Visseren FL;
    Int J Cardiol; 2015 Sep; 195():195-202. PubMed ID: 26046422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
    Burger PM; Pradhan AD; Dorresteijn JAN; Koudstaal S; Teraa M; de Borst GJ; van der Meer MG; Mosterd A; Ridker PM; Visseren FLJ;
    Am J Cardiol; 2023 Jun; 197():13-23. PubMed ID: 37218417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.
    Weijmans M; van der Graaf Y; de Borst GJ; Asselbergs FW; Cramer MJ; Algra A; Visseren FL;
    Am Heart J; 2015 Oct; 170(4):744-752.e2. PubMed ID: 26386798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study - protocol for a multicentre cross-sectional study.
    de Vos LC; Boersema J; Hillebrands JL; Schalkwijk CG; Meerwaldt R; Breek JC; Smit AJ; Zeebregts CJ; Lefrandt JD
    BMJ Open; 2017 Apr; 7(4):e012584. PubMed ID: 28400456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased arterial stiffness is independently related to cerebrovascular disease and aneurysms of the abdominal aorta: the Second Manifestations of Arterial Disease (SMART) Study.
    Dijk JM; van der Graaf Y; Grobbee DE; Banga JD; Bots ML;
    Stroke; 2004 Jul; 35(7):1642-6. PubMed ID: 15143289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
    Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
    Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study.
    Tsai CL; Lin CL; Wu YY; Shieh DC; Sung FC; Kao CH
    Diabetes Metab Res Rev; 2015 Feb; 31(2):190-7. PubMed ID: 25066630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis.
    Berkelmans GFN; van der Graaf Y; Dorresteijn JAN; de Borst GJ; Cramer MJ; Kappelle LJ; Westerink J; Visseren FLJ;
    Int J Cardiol; 2018 Jan; 251():96-102. PubMed ID: 28728850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease.
    Hageman SHJ; de Borst GJ; Dorresteijn JAN; Bots ML; Westerink J; Asselbergs FW; Visseren FLJ;
    Heart; 2020 Nov; 106(21):1686-1692. PubMed ID: 32170038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study.
    Dikilitas O; Satterfield BA; Kullo IJ
    J Am Heart Assoc; 2020 Dec; 9(24):e017740. PubMed ID: 33287626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Gorter PM; Olijhoek JK; van der Graaf Y; Algra A; Rabelink TJ; Visseren FL;
    Atherosclerosis; 2004 Apr; 173(2):363-9. PubMed ID: 15064114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.
    van der Meer MG; Cramer MJ; van der Graaf Y; Appelman Y; Doevendans PA; Nathoe HM;
    Eur J Clin Invest; 2014; 44(3):231-9. PubMed ID: 24372467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.